Yes and all those proven SOC options so far with Fauci’s blessings have proven to be so much better lol. All of them have gained approval by being watered down, rushed through and now have been found out to be useless. Same thing with Le Zulu Mab. Three changes to meet watered down endpoint and no inventory ready for a year to treat a minimal amount of patients. Let’s be realistic here. Based on the small slice of what we know works Leronlimab, countless lives would have been saved by now. The reason Leronlimab will have difficulty getting any approvals in Covid is because the path would show the incompetence of the FDA with their own statements how ridiculous they look. Blood on their hands would be obvious. So instead of any approvals which would put most of their budget on the chopping block, they make it impossible to gain EUA. And as such Leronlimab would wipe out a good portion of BP revenues. Here go off to foreign lands to make a difference where they understand that citizens come first and saving lives. Good luck with HGEN
Market Data 
Markets 
AI
